This website uses cookies to enhance the user experience.
||
A

ASINVEST AS918 187 642

Limited company
Bygdavegen 521 6200 STRANDA, Norge

ASINVEST AS

Organization

CEO
AS

André Skarbø1973

Chairman of the board
AS

André Skarbø1973

Years since formation
9 years
since Dec 13, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
5,730,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
24,096,000
NOK
Annual total result 2024
7,947,242
NOK
Total equity 2024
150,003,899
NOK
Last update: Sep 9, 2025

Management

Management / administration

NameRoleShares
AS

André Skarbø

1973

Managing Director/CEO
100 %
directly

Board

NameRoleShares
AS

André Skarbø

1973

Chairman
100 %
directly

Others

NameRoleShares
B
BDO AS
Auditor-
A
ACCOUNTOR NORDVEST AS
Accountant-

Top 10 individual shareholders

NameRoleShares
AS

André Skarbø

1973

Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
AS

André Skarbø

1973

Ordinary shares
5,730,000
100 %

Shares owned by the ASINVEST AS

NameShare classTotal number of sharesShare
P
PLATINA SEAFOOD AS
Ordinary shares
500
100 %
P
PLATINA SEAFOOD MARKED AS
Ordinary shares
3,212,500
90.49 %
A
ALSVÅG LAKSESLAKTERI AS
Ordinary shares
2,625
33.33 %
P
PURECOD AS
Ordinary shares
10,000
25 %
V
VÅRDUGG AS
Ordinary shares
25
25 %
I
INCREMENTUM EIENDOM AS
Ordinary shares
48,750
20 %
A
AKVAKULTURPARTNER AS
Ordinary shares
5,000
20 %
E
EIKLAKS AS
Ordinary shares
240
12 %
A
AURELAKS AS
Ordinary shares
240
12 %
S
SESSLAKS AS
Ordinary shares
100
10 %
N
NESSEBY SMOLT AS
Ordinary shares
195,661
9.78 %
N
NORSK EDELFISK AS
Ordinary shares
16,827
4.93 %
H
HOFSETH INTERNATIONAL AS
A-shares
41,771,095
3.8 %
G
GEDDIT AS
NO0010732266
1,021,000
0.63 %
A
AQUA BIO TECHNOLOGY ASA
NO0010307135
239,461
0.22 %
V
VINO PIEMONTE AS
Ordinary shares
5,581
0.13 %
H
HOFSETH BIOCARE ASA
NO0010598683
255,000
0.06 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
28,500
< 0.01 %
D
DNB BANK ASA
NO0010161896
10,000
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • ASINVEST AS
    Total operating income 2024: NOK 24,096,000
    Operating profit 2024: NOK 20,461,515
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
24,096,000
7,557,950
1,666,200
0
Annual Total Result
7,947,242
52,676,137
-19,061,151
-34,757,964
Total assets
175,760,800
239,356,213
197,041,232
247,622,276
Total liabilities
25,756,901
79,799,556
66,960,712
83,880,605
Total equity
150,003,899
159,556,657
130,080,520
163,741,671

P&L

Year2024202320222021
Total operating income
24,096,000
7,557,950
1,666,200
0
Total operating costs
3,634,485
438,881
561,799
359,739
Operating result
20,461,515
7,119,069
1,104,401
-359,739
Financial income/costs
-8,096,803
46,717,264
-20,165,552
-34,398,225
Profit before tax
12,364,712
53,836,333
-19,061,151
-34,757,964
Total tax & extraordinary income/cost
4,417,470
1,160,196
0
0
Annual Total Result
7,947,242
52,676,137
-19,061,151
-34,757,964

Balance overview

Year2024202320222021
Total fixed assets
161,861,991
154,519,455
152,535,626
138,261,169
Total current assets
13,898,809
84,836,758
44,505,607
109,361,107
Total assets
175,760,800
239,356,213
197,041,232
247,622,276
Short term debt
24,309,817
15,419,296
11,102,643
27,639,875
Long term debt
1,447,084
64,380,260
55,858,070
56,240,730
Total liabilities
25,756,901
79,799,556
66,960,712
83,880,605
Contributed capital
100,049,319
100,049,319
100,049,319
100,049,319
Retained earnings
49,954,580
59,507,338
30,031,201
63,692,352
Total equity
150,003,899
159,556,657
130,080,520
163,741,671
Total equity and liabilities
175,760,800
239,356,213
197,041,232
247,622,276

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises